Profile data is unavailable for this security.
About the company
PW Medtech Group Ltd is a company principally engaged in the research and development (R&D) and sales of medical devices. The Company operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The Company mainly operates its businesses in the domestic market.
- Revenue in HKD (TTM)960.11m
- Net income in HKD166.55m
- Incorporated2011
- Employees1.36k
- LocationPW Medtech Group LtdLevel 54Hopewell Centre, 183 Queen's Road EastBEIJING 101204ChinaCHN
- Phone+86 1 084783617
- Fax+86 1 084783657
- Websitehttps://www.pwmedtech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaisa Health Group Holdings Ltd | 166.42m | -31.22m | 1.01bn | 917.00 | -- | 2.31 | -- | 6.06 | -0.0062 | -0.0062 | 0.033 | 0.0865 | 0.308 | 6.69 | 1.52 | 193,284.50 | -6.59 | -7.25 | -7.83 | -9.34 | 41.58 | 45.27 | -21.40 | -28.20 | 3.89 | -- | 0.0257 | -- | -0.2824 | -5.93 | -720.72 | -- | -19.69 | -- |
| Venus MedTech HangZhou Inc | 485.53m | -730.25m | 1.06bn | 605.00 | -- | 0.4526 | -- | 2.19 | -1.67 | -1.67 | 1.11 | 5.32 | 0.1218 | 0.9065 | 2.08 | 702,651.20 | -18.34 | -13.83 | -21.01 | -15.57 | 75.83 | 78.74 | -150.57 | -151.55 | 1.56 | -32.63 | 0.1928 | -- | -4.18 | 15.08 | -1.50 | -- | 11.12 | -- |
| Shanghai Bio-heart Biologicl Tech Co Ltd | 23.71m | -101.51m | 1.16bn | 70.00 | -- | 2.14 | -- | 48.87 | -0.417 | -0.417 | 0.0974 | 2.23 | 0.0251 | 0.8435 | 3.43 | 376,314.70 | -11.04 | -30.86 | -12.96 | -32.99 | 46.47 | -- | -439.71 | -- | 11.95 | -1.47 | 0.203 | -- | -- | -- | 50.00 | -- | 25.75 | -- |
| Beijing Airdoc Technology Co Ltd | 166.34m | -200.72m | 1.17bn | 193.00 | -- | 0.8208 | -- | 7.06 | -1.96 | -1.96 | 1.63 | 13.96 | 0.1002 | 1.57 | 2.80 | 589,846.10 | -12.54 | -12.40 | -13.31 | -13.54 | 66.29 | 56.72 | -125.12 | -128.07 | 8.71 | -- | 0.0098 | -- | -23.34 | 38.74 | -92.75 | -- | 1.28 | -- |
| Cryofocus Medtech (Shanghai) Co Ltd | 96.78m | -86.38m | 1.39bn | 180.00 | -- | 20.70 | -- | 14.31 | -0.3613 | -0.3613 | 0.4048 | 0.2734 | 0.4945 | 1.12 | -- | 350,648.90 | -47.93 | -- | -72.64 | -- | 67.45 | -- | -96.93 | -- | 1.40 | -54.78 | 0.3918 | -- | 30.72 | -- | -7.06 | -- | -- | -- |
| Shanghai HeartCare Medcl Tech Corp Ltd | 380.63m | 48.22m | 1.62bn | 327.00 | 34.26 | 1.31 | 19.58 | 4.24 | 1.25 | 1.25 | 9.97 | 32.62 | 0.2736 | 0.7131 | 3.54 | 1,106,472.00 | 3.47 | -13.27 | 3.66 | -13.97 | 67.49 | 66.65 | 12.67 | -90.50 | 13.16 | -- | 0.0396 | -- | 19.61 | -- | 85.51 | -- | -24.35 | -- |
| Sisram Medical Ltd | 2.70bn | 161.11m | 1.73bn | 1.04k | 10.76 | 0.4751 | 5.29 | 0.6406 | 0.344 | 0.344 | 5.78 | 7.79 | 0.549 | 1.55 | 3.90 | 2,664,947.00 | 3.90 | 5.64 | 4.82 | 6.66 | 60.93 | 58.95 | 7.10 | 9.80 | 1.73 | -- | 0.0879 | 28.86 | -2.83 | 15.01 | -20.23 | 3.87 | 41.74 | 2.81 |
| Ethk Labs Inc | 3.50bn | 198.02m | 1.78bn | 877.00 | 9.17 | 0.4568 | 7.29 | 0.509 | 0.1211 | 0.1211 | 2.14 | 2.43 | 0.536 | 1.06 | 6.84 | 4,053,870.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
| PW Medtech Group Ltd | 960.11m | 166.55m | 1.90bn | 1.36k | 11.66 | 0.4351 | 5.21 | 1.98 | 0.1106 | 0.1106 | 0.6383 | 2.97 | 0.1603 | 2.91 | 11.47 | 678,521.40 | 3.52 | 7.71 | 4.42 | 8.74 | 52.62 | 56.56 | 21.96 | 75.91 | 9.12 | -- | 0.0042 | 8.38 | 13.90 | 16.25 | -1.57 | 12.96 | 8.75 | -- |
Data as of Mar 05 2026. Currency figures normalised to PW Medtech Group Ltd's reporting currency: Hong Kong Dollar HKD
0.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 9.14m | 0.62% |
| AXA Investment Managers UK Ltd.as of 31 Dec 2025 | 935.00k | 0.06% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 422.21k | 0.03% |
| DFA Australia Ltd.as of 30 Nov 2025 | 26.27k | 0.00% |
| American Century Investment Management, Inc.as of 31 Dec 2025 | 7.00k | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
